Credit Given Where Due, However., page-21

It’s a confidential contract. Pretty standard.

DoD is doing the heavy lifting but the trials wouldn’t be expensive. If they get FDA approval and US military approval that will be a big marketing bonus for Travelan and open it up for widespread International marketing. But also approves Travelan platform technology making the company attractive to bigger investors.

The new manager is excited about C-diff getting into clinical trials next year. Let’s see if he delivers on that. Immuron has been all talk and no action on that front for years.